Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(23), P. 7128 - 7128
Published: Nov. 25, 2024
The COVID-19 pandemic posed significant challenges in the treatment of chronic diseases, particularly inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis. These are multifaceted, encompassing difficulties maintaining routine care, concerns about safety immunosuppressive therapies, disruptions healthcare delivery, complexities managing IBD patients who contract COVID-19. This article explores various obstacles faced during discusses potential strategies to overcome these challenges.
Language: Английский